Official Title: A Phase II Study Of Epothilone B Analog BMS 247550 NSC 710428 In Stage IV Malignant Melanoma
Status: COMPLETED
Status Verified Date: 2013-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have stage IV melanoma Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
Detailed Description: OBJECTIVES
I Determine the efficacy of BMS-247550 in patients with stage IV melanoma II Determine the toxicity of this drug in these patients
OUTLINE This is a multicenter study Patients are stratified according to the number of prior chemotherapy regimens 0 vs 1-2 including dacarbazine or temozolomide
Patients receive BMS-247550 IV over 1 hour on days 1 8 and 15 Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity